BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 31465299)

  • 1. Siglec-8 antibody reduces eosinophils and mast cells in a transgenic mouse model of eosinophilic gastroenteritis.
    Youngblood BA; Brock EC; Leung J; Falahati R; Bochner BS; Rasmussen HS; Peterson K; Bebbington C; Tomasevic N
    JCI Insight; 2019 Oct; 4(19):. PubMed ID: 31465299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sialic acid-binding immunoglobulin-like lectin (Siglec) 8 in patients with eosinophilic disorders: Receptor expression and targeting using chimeric antibodies.
    Legrand F; Cao Y; Wechsler JB; Zhu X; Zimmermann N; Rampertaap S; Monsale J; Romito K; Youngblood BA; Brock EC; Makiya MA; Tomasevic N; Bebbington C; Maric I; Metcalfe DD; Bochner BS; Klion AD
    J Allergy Clin Immunol; 2019 Jun; 143(6):2227-2237.e10. PubMed ID: 30543818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AK002, a Humanized Sialic Acid-Binding Immunoglobulin-Like Lectin-8 Antibody that Induces Antibody-Dependent Cell-Mediated Cytotoxicity against Human Eosinophils and Inhibits Mast Cell-Mediated Anaphylaxis in Mice.
    Youngblood BA; Brock EC; Leung J; Falahati R; Bryce PJ; Bright J; Williams J; Shultz LD; Greiner DL; Brehm MA; Bebbington C; Tomasevic N
    Int Arch Allergy Immunol; 2019; 180(2):91-102. PubMed ID: 31401630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mast Cell and Eosinophil Activation Are Associated With COVID-19 and TLR-Mediated Viral Inflammation: Implications for an Anti-Siglec-8 Antibody.
    Gebremeskel S; Schanin J; Coyle KM; Butuci M; Luu T; Brock EC; Xu A; Wong A; Leung J; Korver W; Morin RD; Schleimer RP; Bochner BS; Youngblood BA
    Front Immunol; 2021; 12():650331. PubMed ID: 33777047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-Siglec-8 Antibody for Eosinophilic Gastritis and Duodenitis.
    Dellon ES; Peterson KA; Murray JA; Falk GW; Gonsalves N; Chehade M; Genta RM; Leung J; Khoury P; Klion AD; Hazan S; Vaezi M; Bledsoe AC; Durrani SR; Wang C; Shaw C; Chang AT; Singh B; Kamboj AP; Rasmussen HS; Rothenberg ME; Hirano I
    N Engl J Med; 2020 Oct; 383(17):1624-1634. PubMed ID: 33085861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery, Function, and Therapeutic Targeting of Siglec-8.
    Youngblood BA; Leung J; Falahati R; Williams J; Schanin J; Brock EC; Singh B; Chang AT; O'Sullivan JA; Schleimer RP; Tomasevic N; Bebbington CR; Bochner BS
    Cells; 2020 Dec; 10(1):. PubMed ID: 33374255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Siglec-F inhibition reduces esophageal eosinophilia and angiogenesis in a mouse model of eosinophilic esophagitis.
    Rubinstein E; Cho JY; Rosenthal P; Chao J; Miller M; Pham A; Aceves SS; Varki A; Broide DH
    J Pediatr Gastroenterol Nutr; 2011 Oct; 53(4):409-16. PubMed ID: 21970996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leveraging Siglec-8 endocytic mechanisms to kill human eosinophils and malignant mast cells.
    O'Sullivan JA; Carroll DJ; Cao Y; Salicru AN; Bochner BS
    J Allergy Clin Immunol; 2018 May; 141(5):1774-1785.e7. PubMed ID: 28734845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An anti-siglec-8 antibody depletes sputum eosinophils from asthmatic subjects and inhibits lung mast cells.
    Kerr SC; Gonzalez JR; Schanin J; Peters MC; Lambrecht BN; Brock EC; Charbit A; Ansel KM; Youngblood BA; Fahy JV
    Clin Exp Allergy; 2020 Aug; 50(8):904-914. PubMed ID: 32542913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eosinophilic Gastritis/Gastroenteritis.
    Chen PH; Anderson L; Zhang K; Weiss GA
    Curr Gastroenterol Rep; 2021 Jul; 23(8):13. PubMed ID: 34331146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Siglec-8 as a drugable target to treat eosinophil and mast cell-associated conditions.
    Kiwamoto T; Kawasaki N; Paulson JC; Bochner BS
    Pharmacol Ther; 2012 Sep; 135(3):327-36. PubMed ID: 22749793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A monoclonal antibody to Siglec-8 suppresses non-allergic airway inflammation and inhibits IgE-independent mast cell activation.
    Schanin J; Gebremeskel S; Korver W; Falahati R; Butuci M; Haw TJ; Nair PM; Liu G; Hansbro NG; Hansbro PM; Evensen E; Brock EC; Xu A; Wong A; Leung J; Bebbington C; Tomasevic N; Youngblood BA
    Mucosal Immunol; 2021 Mar; 14(2):366-376. PubMed ID: 32814824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Siglec-8 and Siglec-F, the new therapeutic targets in asthma.
    Farid SSh; Mirshafiey A; Razavi A
    Immunopharmacol Immunotoxicol; 2012 Oct; 34(5):721-6. PubMed ID: 22324980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. "Siglec"ting the allergic response for therapeutic targeting.
    Bochner BS
    Glycobiology; 2016 Jun; 26(6):546-52. PubMed ID: 26911285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frontline Science: Characterization of a novel mouse strain expressing human Siglec-8 only on eosinophils.
    O'Sullivan JA; Wei Y; Carroll DJ; Moreno-Vinasco L; Cao Y; Zhang F; Lee JJ; Zhu Z; Bochner BS
    J Leukoc Biol; 2018 Jul; 104(1):11-19. PubMed ID: 29601103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mouse Siglec-F and human Siglec-8 are functionally convergent paralogs that are selectively expressed on eosinophils and recognize 6'-sulfo-sialyl Lewis X as a preferred glycan ligand.
    Tateno H; Crocker PR; Paulson JC
    Glycobiology; 2005 Nov; 15(11):1125-35. PubMed ID: 15972893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Inhibitory Receptor Siglec-8 Interacts With FcεRI and Globally Inhibits Intracellular Signaling in Primary Mast Cells Upon Activation.
    Korver W; Wong A; Gebremeskel S; Negri GL; Schanin J; Chang K; Leung J; Benet Z; Luu T; Brock EC; Luehrsen K; Xu A; Youngblood BA
    Front Immunol; 2022; 13():833728. PubMed ID: 35154156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Developmental, malignancy-related, and cross-species analysis of eosinophil, mast cell, and basophil siglec-8 expression.
    Hudson SA; Herrmann H; Du J; Cox P; Haddad el-B; Butler B; Crocker PR; Ackerman SJ; Valent P; Bochner BS
    J Clin Immunol; 2011 Dec; 31(6):1045-53. PubMed ID: 21938510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-Siglec-F antibody reduces allergen-induced eosinophilic inflammation and airway remodeling.
    Song DJ; Cho JY; Lee SY; Miller M; Rosenthal P; Soroosh P; Croft M; Zhang M; Varki A; Broide DH
    J Immunol; 2009 Oct; 183(8):5333-41. PubMed ID: 19783675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eosinophilic Esophagitis and Gastroenteritis.
    Cianferoni A; Spergel JM
    Curr Allergy Asthma Rep; 2015 Sep; 15(9):58. PubMed ID: 26233430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.